title: Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran.
authors.affiliation: Department of Gynecology, Cancer Institute Hopital, Tokyo.
authors.forename: Y
authors.initials: Y
authors.lastname: Shimizu
authors.forename: J T
authors.initials: JT
authors.lastname: Chen
authors.forename: Y
authors.initials: Y
authors.lastname: Hirai
authors.forename: K
authors.initials: K
authors.lastname: Nakayama
authors.forename: T
authors.initials: T
authors.lastname: Hamada
authors.forename: I
authors.initials: I
authors.lastname: Fujimoto
authors.forename: K
authors.initials: K
authors.lastname: Hasumi
authors.forename: K
authors.initials: K
authors.lastname: Masubuchi
mesh_terms: D003602:Cytotoxicity, Immunologic; D005260:Female; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology* / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology* / Q000378:metabolism; D010388:Pelvis; D012566:Sizofiran / Q000494:pharmacology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology*
chemical_list: D006025:Glycosaminoglycans; D007376:Interleukin-2; D012566:Sizofiran